Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2006-001090-23Phase 4Completed
Phase 4, randomised trial of testosterone in heart failure (HF) and Hypoandrogenism (TD) (2 arms), sponsored by Sheffield Teaching Hospitals NHS Foundation Trust. Primary endpoint: Exercise capacity (ISWT change from baseline to 12 weeks). Started May 2006; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2006-001090-23.